Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Haferkamp

Showing results (131-140 of 298) with videos related to

Pageof 30
Sort By:
Oncotarget|January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cellsEva Juengel, Ramin Najafi, Jochen Rutz, et al.
Annals of Surgical Oncology|December 3, 2009
Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indicationsAxel Haferkamp, Martin Kurosch, Maria Pritsch, et al.
World Journal of Urology|March 15, 2023
Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expectedGregor Duwe, Katharina Boehm, Maximilian Haack, et al.
Urologia Internationalis|September 9, 2015
Globalization in Urology: A Bibliographical Analysis of Cross-Continent Publication between 2002 and 2012Jens Mani, Eva Juengel, Georg Bartsch, et al.
Clinical & Experimental Metastasis|April 1, 2011
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cellsSteffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
BJU International|September 13, 2005
Adherens junctions of the human detrusorNina Wagener, André Reitz, Jesco Pfitzenmaier, et al.
Cancers|October 30, 2020
Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of FerroptosisSascha D Markowitsch, Patricia Schupp, Julia Lauckner, et al.
Patient Preference and Adherence|November 9, 2016
What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospitalJens Mani, Stefan Vallo, Maximilian P Brandt, et al.
Journal of Negative Results in Biomedicine|November 9, 2014
The feasibility of ureteral tissue engineering using autologous veins: an orthotopic animal model with long term resultsOliver Engel, Robert de Petriconi, Björn G Volkmer, et al.
The Journal of Urology|April 18, 2007
Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followupAxel Haferkamp, Patrick J Bastian, Hildegard Jakobi, et al.
Pageof 30

Showing results (131-140 of 298) with videos related to

Sort By:
Pageof 30
Oncotarget|January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cellsEva Juengel, Ramin Najafi, Jochen Rutz, et al.
Annals of Surgical Oncology|December 3, 2009
Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indicationsAxel Haferkamp, Martin Kurosch, Maria Pritsch, et al.
World Journal of Urology|March 15, 2023
Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expectedGregor Duwe, Katharina Boehm, Maximilian Haack, et al.
Urologia Internationalis|September 9, 2015
Globalization in Urology: A Bibliographical Analysis of Cross-Continent Publication between 2002 and 2012Jens Mani, Eva Juengel, Georg Bartsch, et al.
Clinical & Experimental Metastasis|April 1, 2011
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cellsSteffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
BJU International|September 13, 2005
Adherens junctions of the human detrusorNina Wagener, André Reitz, Jesco Pfitzenmaier, et al.
Cancers|October 30, 2020
Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of FerroptosisSascha D Markowitsch, Patricia Schupp, Julia Lauckner, et al.
Patient Preference and Adherence|November 9, 2016
What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospitalJens Mani, Stefan Vallo, Maximilian P Brandt, et al.
Journal of Negative Results in Biomedicine|November 9, 2014
The feasibility of ureteral tissue engineering using autologous veins: an orthotopic animal model with long term resultsOliver Engel, Robert de Petriconi, Björn G Volkmer, et al.
The Journal of Urology|April 18, 2007
Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followupAxel Haferkamp, Patrick J Bastian, Hildegard Jakobi, et al.
Pageof 30